Human inherited CCR2 deficiency underlies progressive polycystic lung disease

Pulmonary and Respiratory Medicine Receptors, CCR2 Chemokine receptor Human Inborn Errors Immunology 610 Trained Immunity in Health and Disease macrophage [SDV.BC]Life Sciences [q-bio]/Cellular Biology Pulmonary Alveolar Proteinosis Alveolar Monocyte Article 618 cystic lung disease Receptors Sciences du Vivant [q-bio]/Biologie cellulaire Macrophages, Alveolar Health Sciences Humans chemotaxis Child Neonatal Lung Development and Respiratory Morbidity Biology Lung Internal medicine Immunology and Microbiology JGM Macrophages Genetic Basis of Primary Immunodeficiency Disorders FOS: Clinical medicine Life Sciences PAP Immune system Chemokine Reinfection monocyte Medicine CCR2 recurrent infection Pulmonary alveolar proteinosis
DOI: 10.1016/j.cell.2023.11.036 Publication Date: 2023-12-28T15:28:07Z
ABSTRACT
We describe a human lung disease caused by autosomal recessive, complete deficiency of the monocyte chemokine receptor C-C motif 2 (CCR2). Nine children from five independent kindreds have pulmonary alveolar proteinosis (PAP), progressive polycystic disease, and recurrent infections, including bacillus Calmette Guérin (BCG) disease. The CCR2 variants are homozygous in six patients compound heterozygous three, all loss-of-expression loss-of-function. They abolish CCR2-agonist ligand (CCL-2)-stimulated Ca2+ signaling migration monocytic cells. All high blood CCL-2 levels, providing diagnostic test for screening with unexplained or mycobacterial Blood myeloid lymphoid subsets interferon (IFN)-γ- granulocyte-macrophage colony-stimulating factor (GM-CSF)-mediated immunity unaffected. CCR2-deficient monocytes macrophage-like cells normal gene expression profiles functions. By contrast, macrophage counts about half. Human is genetic etiology PAP, infections impaired CCL2-dependent to lungs infected tissues.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (108)
CITATIONS (34)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....